Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company focused on developing Alpha DaRT, a localized alpha-radiation treatment platform for solid tumors. Its core technology is designed to deliver alpha-emitting particles directly into cancerous tissue, supporting research and commercialization efforts across multiple tumor types. The company’s current portfolio includes clinical programs in areas such as skin, head and neck, pancreatic, prostate, lung, liver, and breast cancers, with an emphasis on investigational use in medical centers and collaborative studies. Alpha Tau Medical Ltd. is positioned within the broader cancer treatment market as a developer of targeted radiotherapy solutions aimed at addressing tumors that may be difficult to treat with conventional approaches. Headquartered in Jerusalem, Israel, the company remains centered on oncology research, device development, and clinical advancement of its proprietary platform.